PACIFIC-AF (Completed)
Randomized, active comparator-controlled, double-blind, double-dummy, parallel group, dose-finding Phase 2 study to compare the safety of the oral FXIa inhibitor BAY 2433334 to a NOAC (apixaban) in patients with atrial fibrillation (AF)
- Medicine
- Oral FXIa inhibitor BAY 2433334
- Population
- Arrhythmia
- Phase
- II
- Starting year
- 2019
- More information
- Clinicaltrials.gov